Differences in the pattern of antibiotic prescription profile and recurrence rate for possible urinary tract infections in women with and without diabetes

Diabetes Care

Volumn 31, Issue 7, 2008, Pages 1380-1385

  Schneeberger, Caroline ^a,b   Stolk, Ronald P ^a   Devries, J Hans ^b   Schneeberger, Peter M ^c   Herings, Ron M ^d,e   Geerlings, Suzanne E ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; FOSFOMYCIN; NITROFURANTOIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; POSTMENOPAUSE; PREMENOPAUSE; PRESCRIPTION; RECURRENT DISEASE; TREATMENT DURATION; URINARY TRACT INFECTION; AGED; CLINICAL TRIAL; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; REGISTER; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NETHERLANDS; PATIENT SELECTION; POSTMENOPAUSE; PREMENOPAUSE; PRESCRIPTIONS, DRUG; RECURRENCE; REGISTRIES; URINARY TRACT INFECTIONS;

EID: 49649088395     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2188     Document Type: Article

References (21)

1. Shah BR, Hux JE: Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26:510-513, 2003
2. Muller LM, Gorter KJ, Hak E: Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Inject Dis 41:281-288, 2005
3. Carton JA, MaradonaJA, Nuno FJ: Diabetes mellitus and bacteraemia: a comparative study between diabetic and non- diabetic patients. Eur J 1:281-287, Med 1992
4. Nicolle LE: Asymptomatic bacteriuria in diabetic women. Diabetes Care 23:722-723, 2000
5. Nicolle LE: A practical guide to antimicrobial management of complicated urinary tract infection. Drugs 18:243-254, Aging 2001
6. Goettsch WG, Janknegt R, Herings RM: Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol 58:184-189, 2004
7. Lawrenson RA, Logie JW: Antibiotic failure in the treatment of urinary tract infections in young women. J Antimicrob Chemother 48:895-901, 2001
8. Carrie AG, Metge CJ, Collins DM, Harding GK, Zhanel GG: Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethox- azole versus fluoroquinolones in the treatment of community-acquired acute pyelonephritis in women. J Antimicrob Chemother 53:512-517, 2004
9. Meiland R, Geerlings SE, Hoepelman AI: Management of bacterial urinary tract infections in adult patients with diabetes mellitus. Drugs 62:1859-1868, 2002
10. Rubenstein JN, Schaeffer AJ: Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am 17:333-351, 2003
11. Timmermans AE, Baselier PJAM, Winkens RAG, Arets H, Wiersma TJ: NHG standaard Urineweginfecties (eerste herziening). Huisarts Wet 42:613-622, 1999
12. Meiland R, Geerlings SE, De Neeling AJ, Hoepelman AI: Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria. Diabet Med 21:10321034, 2004
13. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Sterga- chis A, Stamm WE: A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335:468-474, 1996
14. Hu KK, Boyko EJ, Scholes D, Normand E, Chen CL, Grafton J, Fihn SD: Risk factors for urinary tract infections in postmeno- pausal women. Arch Intern Med 164:989-993, 2004
15. Hoepelman AI, Meiland R, Geerlings SE: Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 22 (Suppl. 2):35-43, 2003
16. Stapleton A: Urinary tract infections in patients with diabetes. Am J Med 113 (Suppl. 1A):80S-84S, 2002
17. Geerlings SE, Stolk RP, Camps MJ, Netten PM, Collet JT, Schneeberger PM, Hoepel- man AI: Consequences of asymptomatic bacteriuria in women with diabetes melli- tus. ArchInternMed 161:1421-1427, 2001
18. Nicolle LE: Urinary tract infection in diabetes. Curr Opin Inject Dis 18:49-53, 2005
19. Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE: Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 142: 20-27, 2005
20. Stolk RP, Pols HA, Lamberts SW, de Jong PT, Hofman A, Grobbee DE: Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population: the Rotterdam Study. Am J Epidemiol 145:24-32, 1997
21. Geerlings SE, Stolk RP, Camps MJ, Netten PM, Hoekstra JB, Bouter KP, Bravenboer B, Collet JT, Jansz AR, Hoepelman AI: Asymptomatic bacteriuria may be considered a complication in women with diabetes: Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744-749, 2000